South Dakota Investment Council decreased its position in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 9.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 40,921 shares of the company’s stock after selling 4,400 shares during the period. South Dakota Investment Council’s holdings in Tenet Healthcare were worth $10,458,000 as of its most recent SEC filing.
Several other hedge funds also recently made changes to their positions in THC. Manning & Napier Advisors LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at $168,761,000. Aberdeen Group plc boosted its position in Tenet Healthcare by 4,392.9% during the 3rd quarter. Aberdeen Group plc now owns 845,555 shares of the company’s stock valued at $216,090,000 after buying an additional 826,735 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in Tenet Healthcare by 57.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after acquiring an additional 244,901 shares during the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Tenet Healthcare in the second quarter valued at about $106,342,000. Finally, Empowered Funds LLC increased its position in shares of Tenet Healthcare by 22.1% in the first quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock valued at $53,736,000 after acquiring an additional 51,549 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.
Tenet Healthcare Stock Down 3.2%
Shares of Tenet Healthcare stock opened at $282.32 on Wednesday. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 1.76. The company’s fifty day simple moving average is $268.81 and its two-hundred day simple moving average is $225.85. The company has a market cap of $22.47 billion, a P/E ratio of 8.19, a PEG ratio of 1.56 and a beta of 1.20. Tenet Healthcare Corporation has a 12-month low of $157.58 and a 12-month high of $301.44.
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, topping the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a net margin of 13.09% and a return on equity of 28.22%. The firm had revenue of $6.28 billion during the quarter, compared to analysts’ expectations of $5.49 billion. During the same period last year, the company posted $3.70 EPS. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. Research analysts anticipate that Tenet Healthcare Corporation will post 22.32 EPS for the current year.
Insider Activity at Tenet Healthcare
In related news, CEO Saumya Sutaria sold 50,000 shares of the stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $278.71, for a total value of $13,935,500.00. Following the completion of the transaction, the chief executive officer directly owned 483,564 shares of the company’s stock, valued at $134,774,122.44. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Lisa Foo sold 24,000 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the sale, the executive vice president owned 8,053 shares of the company’s stock, valued at $2,144,674.96. This trade represents a 74.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 99,462 shares of company stock valued at $27,081,234 over the last three months. Corporate insiders own 0.97% of the company’s stock.
Wall Street Analysts Forecast Growth
THC has been the subject of several recent analyst reports. Stephens reaffirmed an “overweight” rating and set a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. Robert W. Baird raised their target price on Tenet Healthcare from $210.00 to $280.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 28th. Zacks Research downgraded Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 29th. Leerink Partners upped their price target on Tenet Healthcare from $309.00 to $342.00 and gave the company an “outperform” rating in a research report on Monday, November 2nd. Finally, KeyCorp lifted their price objective on Tenet Healthcare from $270.00 to $300.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 3rd. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $296.65.
Get Our Latest Stock Analysis on Tenet Healthcare
Tenet Healthcare Profile
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
